The activist investors’ strong message to Bed Bath & Beyond (BBBY) in the last month has raised the confidence of the analysts and shareholders, and helped the home goods retailer’s stock to surge 34% in the last two weeks. In this scenario, Bed Bath & Beyond is set to release its fourth quarter and full-year 2018 financial results on Wednesday, April 10 after the market close.
Market watchers expect Bed Bath & Beyond’s Q4 earnings to decline 25% to $1.11 per share and sales to drop 10% to $3.33 billion compared to the prior year quarter’s profit of $1.48 per share and sales of $3.71 billion.
On March 26, a group of activist investors (Legion Partners, Macellum Advisors and Ancora Advisors) nominated 16 candidates for the Bed Bath’s Board of Directors. The activist group accused that during Bed Bath & Beyond’s CEO Steven Temares 15-year tenure, the company had lost above $8 billion in market value and since early 2015, the stock had plunged over 80%.
The activist investors also stated that the management had failed in adapting its business model according to the changing retail landscape and paid high executive compensation. They also added that the company’s board of directors lacked retail experience.
Bed Bath & Beyond responded to the activist investors group’s press release by stating that the many areas highlighted by them are already addressed by the company. The Union, New Jersey-based firm added that it already mentioned in Q3 conference call that the company is ahead of plan with respect to its long-term financial goals.
The activist investors attack on the company had helped its stock price pop up in the past two weeks and on Friday, Morgan Stanley analyst Simeon Gutman upgraded the stock from Under Weight to Equal Weight, with a new 12-month price target of $20.
For the third quarter 2018, Bed Bath & Beyond’s earnings beat the Street’s estimates, while sales missed the expectations. Higher expenses dented the company’s profit. However, the company’s FY19 outlook surpassed the targets. Comparable store sales for the quarter dropped 1.8%.
What to expect
Investors will be looking how management defends its position with regards to the activist group’s comments. The market will also keenly observe the company’s outlook and its future plans
Shares of Bed Bath & Beyond, which slumped to its 5-year low during December end, closed the Friday’s session up 4.32% at $18.35. The stock had surged 62% since the beginning of this year and lost 15% in the past 12 months.
Colgate-Palmolive Company (NYSE: CL) reported fourth quarter 2022 earnings results today. Net sales increased 5% year-over-year to $4.62 billion. Organic sales growth was 8.5%. Net income attributable to Colgate-Palmolive Company was
Chevron Corporation (NYSE: CVX) reported fourth quarter 2022 earnings results today. Total revenues and other income were $56.4 billion compared to $48.1 billion in the year-ago period. Net income attributable
American Express Company (NYSE: AXP) reported fourth quarter 2022 earnings results. Consolidated total revenues net of interest expense were $14.2 billion, up 17% from a year ago. Net income was